As the global economy mends, the 2021 growth of Epirubicin Hydrochloride Injection will have significant change from previous year. According to our (LP Information) latest study, the global Epirubicin Hydrochloride Injection market size is USD million in 2022 from USD million in 2021, with a change of % between 2021 and 2022. The global Epirubicin Hydrochloride Injection market size will reach USD million in 2028, growing at a CAGR of % over the analysis period 2022-2028.
The United States Epirubicin Hydrochloride Injection market is expected at value of US$ million in 2021 and grow at approximately % CAGR during forecast period 2022-2028. China constitutes a % market for the global Epirubicin Hydrochloride Injection market, reaching US$ million by the year 2028. As for the Europe Epirubicin Hydrochloride Injection landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period 2022-2028. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 6-year period.
Global main Epirubicin Hydrochloride Injection players cover Akorn, Aurobindo Pharma, Cipla, and Ebewe Pharma, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
This report presents a comprehensive overview, market shares, and growth opportunities of Epirubicin Hydrochloride Injection market by product type, application, key manufacturers and key regions and countries.
Segmentation by type: breakdown data from 2017 to 2022, in Section 2.3; and forecast to 2028 in section 12.6
5mg
10mg
Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 12.7.
Leukemia
Malignant Lymphoma
Multiple Myeloma
Breast Cancer
Lung Cancer
Soft Tissue Sarcoma
Stomach Cancer
Colorectal Cancer
Ovarian Cancer
Others
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the prominent manufacturers in this market, include
Akorn
Aurobindo Pharma
Cipla
Ebewe Pharma
Fresenius Kabi Usa
Impax Laboratories
Mylan Laboratories
Nippon Kayaku
Pfizer
Sawai Pharmaceutical
Zennova
Beijing Union Pharmaceutical Factory
Hisun Pharmaceutical
Hanhui Pharmaceutical
Lunan Pharmaceutical